FUSN - Fusion Pharmaceuticals Inc.
IEX Last Trade
21.555
21.555 100.000%
Share volume: 0
Last Updated: Mon 03 Jun 2024 08:15:20 PM CEST
Biological Product (except Diagnostic) Manufacturing :
-4.32%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
17%
Profitability
0%
Dept financing
23%
Liquidity
75%
Performance
18%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.23%
Return on assets
-8.64%
Return on sales
-22116.86%
Return on invested capital
-92.86%
Total debt ratio
15.85%
Debt ratio change over timeo
-1.26%
Current Ratio
16.51%
Quick Ratio
16.51%
Cash Position Ratio
15.8%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.21%
Return on assets
-9.52%
Return on sales
-46435.69%
Return on invested capital
-73.59%
Total debt ratio
25.14%
Debt ratio change over timeo
-1.5%
Current Ratio
12.1%
Quick Ratio
12.1%
Cash Position Ratio
11.5%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
-9.15%
Return on assets
-7.65%
Return on sales
-966.55%
Return on invested capital
-52.87%
Total debt ratio
25.62%
Debt ratio change over time
-1.48%
Current Ratio
11.63%
Quick Ratio
11.63%
Cash Position Ratio
10.95%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-83.21%
Return on assets
-85.76%
Return on sales
46853.3%
Return on invested capital
13.14%
Total debt ratio
-126.41%
Debt ratio change over time
-1.26%
Current Ratio
-30.23%
Quick Ratio
-30.23%
Cash Position Ratio
-29.04%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | FUSN | SGEN | NK | SRNG |
---|---|---|---|---|
Return on equity | -10.23% | -2.6% | -14.24% | 0% |
Return on assets | -8.64% | -2.4% | -12.07% | 0% |
Return on sales | -22116.86% | -25.64% | 0% | 0% |
Return on invested capital | -92.86% | -55.3% | -26.3% | 0% |
Profitability | 0% | 0% | 25% | 75% |
Total debt ratio | 15.85% | 19.36% | 16.14% | 0% |
Debt ratio change over time | -1.26% | -1.42% | -1.73% | 0% |
Dept financing | 20% | 25% | 21% | 25% |
Current Ratio | 12.1% | 3.26% | 0% | 0% |
Quick Ratio | 12.1% | 2.66% | 0% | 0% |
Cash Position Ratio | 11.5% | 1.8% | 0% | 0% |
Liquididy | 75% | 18% | 12% | 0% |
Short-term ratios | FUSN | SGEN | NK | SRNG |
---|---|---|---|---|
Return on equity | -12.21% | -7.06% | 0% | 0% |
Return on assets | -9.52% | -5.52% | 0% | 0% |
Return on sales | -46435.69% | -34.22% | 0% | 0% |
Return on invested capital | -73.59% | -154.82% | 0% | 0% |
Profitability | 0% | 0% | 100% | 0% |
Total debt ratio | 25.14% | 25.43% | 0% | 0% |
Debt ratio change over time | -1.5% | -1.21% | 0% | 0% |
Dept financing | 25% | 25% | 25% | 0% |
Current Ratio | 12.1% | 3.26% | 0% | 0% |
Quick Ratio | 12.1% | 2.66% | 0% | 0% |
Cash Position Ratio | 11.5% | 1.8% | 0% | 0% |
Liquididy | 75% | 16% | 0% | 0% |